Anti-Amyloid Drug Shows Potential in Preventing Alzheimer’s Disease
Alzheimer’s disease, a progressive neurodegenerative disorder, affects millions of people worldwide, leading to memory loss, cognitive…
NewTreatment
FDA Grants Approval for Tremfya to Treat Active Crohn’s Disease in Adults
The U.S. Food and Drug Administration (FDA) has officially approved Tremfya (guselkumab) for the treatment of adults suffering from…